Get started
Author

Chihaya Imai

Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
2004 · C Imai, K Mihara, et al. · Leukemia · 862
Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells
2005 · Chihaya Imai, Shotaro Iwamoto, et al. · Blood · 676
Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
2009 · Hiroyuki Fujisaki, Harumi Kakuda, et al. · Cancer Research · 612
PDF
Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15
2014 · Masaru Imamura, David Shook, et al. · Blood · 190
T Lymphocytes Expressing a CD16 Signaling Receptor Exert Antibody-Dependent Cancer Cell Killing
2013 · Ko Kudo, Chihaya Imai, et al. · Cancer Research · 190
Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase
2003 · Keichiro Mihara, Chihaya Imai, et al. · British Journal of Haematology · 143
Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations
2017 · Charline Miot, Kohsuke Imai, et al. · Blood · 111
PDF
Replicative potential of human natural killer cells
2009 · Hiroyuki Fujisaki, Harumi Kakuda, et al. · British Journal of Haematology · 105
PDF
Synthetic Messenger RNA as a Tool for Gene Therapy
2006 · Pter M. Rabinovich, Marina E. Komarovskaya, et al. · Human Gene Therapy · 74
All‐trans retinoic acid enhances cytotoxic effect of T cells with an anti‐CD38 chimeric antigen receptor in acute myeloid leukemia
2016 · Tetsumi Yoshida, Keichiro Mihara, et al. · Clinical & Translational Immunology · 70
PDF
Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan
2016 · T Imamura, N Kiyokawa, et al. · Blood Cancer Journal · 68
PDF
Activated T–cell-mediated Immunotherapy With a Chimeric Receptor Against CD38 in B-cell Non-Hodgkin Lymphoma
2009 · Keichiro Mihara, Kazuyoshi Yanagihara, et al. · Journal of Immunotherapy · 60
Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34+ cells of juvenile myelomonocytic leukemia
2016 · Yozo Nakazawa, Kazuyuki Matsuda, et al. · Journal of Hematology & Oncology · 56
PDF
4-1BB Chimeric Antigen Receptors
2014 · Dario Campana, Herbert Schwarz, et al. · The Cancer Journal · 55
Synergistic and persistent effect of T‐cell immunotherapy with anti‐CD19 or anti‐CD38 chimeric receptor in conjunction with rituximab on B‐cell non‐Hodgkin lymphoma
2010 · Keichiro Mihara, Kazuyoshi Yanagihara, et al. · British Journal of Haematology · 53
PDF
Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients
2022 · Christoph B. Geier, Maryssa Ellison, et al. · Journal of Clinical Immunology · 51
PDF
Enhancement of the anti-leukemic activity of cytokine induced killer cells with an anti-CD19 chimeric receptor delivering a 4-1BB-ζ activating signal
2007 · Virna Marin, Harumi Kakuda, et al. · Experimental Hematology · 49
PDF
Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma
2021 · Sakiko Harada, Miki Ando, et al. · Molecular Therapy · 45
Landscape of driver mutations and their clinical effects on Down syndrome–related myeloid neoplasms
2024 · Tomohiko Sato, Kenichi Yoshida, et al. · Blood · 34
Frequent somatic mosaicism of NEMO in T cells of patients with X-linked anhidrotic ectodermal dysplasia with immunodeficiency
2012 · Tomoki Kawai, Ryuta Nishikomori, et al. · Blood · 34
Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group
2023 · Atsushi Sato, Yoshihiro Hatta, et al. · The Lancet Haematology · 30
PDF
Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia
2022 · Haruko Shima, Akiko Kada, et al. · Pediatric Blood & Cancer · 29
Autoimmunity and persistent RAS-mutated clones long after the spontaneous regression of JMML
2013 · M Takagi, J Piao, et al. · Leukemia · 29
Donor Killer Immunoglobulin-Like Receptor Haplotype B/x Induces Severe Acute Graft-versus-Host Disease in the Presence of Human Leukocyte Antigen Mismatch in T Cell–Replete Hematopoietic Cell Transplantation
2016 · Ryosuke Hosokai, Masayoshi Masuko, et al. · Transplantation and Cellular Therapy · 28
PDF
Antitumor effects of intracranial injection of B7-H3-targeted Car-T and Car-Nk cells in a patient-derived glioblastoma xenograft model
2024 · Tetsuro Tachi, Noriyuki Kijima, et al. · Cancer Immunology Immunotherapy · 27
PDF
Works count: 135
Citation count: 4,235
H-index: 27
I10-index: 43
Year
Topic
Type